Delaware Federal Judge: Harm Not Irreparable In Pharmaceutical Patent Case
WILMINGTON, Del. — A request by Bayer Pharma AG, Bayer Intellectual Property GmbH and Bayer HealthCare Pharmaceuticals Inc. (Bayer, collectively) for a preliminary injunction barring a competitor from selling a generic...To view the full article, register now.
Already a subscriber? Click here to view full article